Back
Akebia Therapeutics Stock Price Chart
Sleep well at night with 7 stellar stocks to buy and hold forever
Get the complete list FREE for a limited time.
Buy
57
AKBA
Akebia Therapeutics
Last Price:
$3.56
Seasonality Move:
-3.14%
7 Day Trial
ALL ACCESS PASS
$
7
7 Stocks to Buy and Hold Forever
The result is a select group of high-quality blue-chip stocks.-
The current trend is moderately bullish and AKBA is experiencing slight selling pressure.
Akebia Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.73 | Sell |
| 20-day SMA: | 3.26 | Buy |
| 50-day SMA: | 2.6 | Buy |
| 200-day SMA: | 2 | Buy |
| 8-day EMA: | 3.61 | Sell |
| 20-day EMA: | 3.31 | Buy |
| 50-day EMA: | 2.83 | Buy |
| 200-day EMA: | 2.13 | Buy |
Akebia Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.33 | Buy |
| Relative Strength Index (14 RSI): | 62.64 | Buy |
| Chaikin Money Flow: | -3067786 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.61 - 3.59) | Buy |
| Bollinger Bands (100): | (1.79 - 2.89) | Buy |
Akebia Therapeutics Technical Analysis
| Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 9 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Akebia Therapeutics Stock
Is Akebia Therapeutics Stock a Buy?
-
Akebia Therapeutics share price is 3.56 while AKBA 8-day simple moving average is 3.73, which is a Sell signal.
-
The stock price of AKBA is 3.56 while Akebia Therapeutics 20-day SMA is 3.26, which makes it a Buy.
-
Akebia Therapeutics 50-day simple moving average is 2.60 while AKBA share price is 3.56, making it a Buy technically.
-
AKBA stock price is 3.56 and Akebia Therapeutics 200-day simple moving average is 2.00, creating a Buy signal.
AKBA Technical Analysis vs Fundamental Analysis
Buy
57
Akebia Therapeutics (AKBA)
is a Buy
Is Akebia Therapeutics a Buy or a Sell?
-
Akebia Therapeutics stock is rated a BuyThe current Akebia Therapeutics [AKBA] share price is $3.56. The Score for AKBA is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
Akebia Therapeutics Stock Info
Market Cap:
935M
Price in USD:
3.56
Share Volume:
6.5M
Akebia Therapeutics 52-Week Range
52-Week High:
4.08
52-Week Low:
0.80
Buy
57
Akebia Therapeutics (AKBA)
is a Buy
Akebia Therapeutics Share Price Forecast
-
What is the Akebia Therapeutics stock price today?The Akebia Therapeutics stock price is 3.56 USD today.
-
Will AKBA stock go up or go down?Akebia Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Akebia Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Akebia Therapeutics is not overvalued.
Is Akebia Therapeutics Stock a Buy?
-
Akebia Therapeutics share price is 3.56 while AKBA 8-day exponential moving average is 3.61, which is a Sell signal.
-
The stock price of AKBA is 3.56 while Akebia Therapeutics 20-day EMA is 3.31, which makes it a Buy.
-
Akebia Therapeutics 50-day exponential moving average is 2.83 while AKBA share price is 3.56, making it a Buy technically.
-
AKBA stock price is 3.56 and Akebia Therapeutics 200-day simple moving average is 2.13, creating a Buy signal.
Fundamental Analysis of Akebia Therapeutics
Is Akebia Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.03 per share, an increase next quarter of $0.12 per share, an increase this year of $0.21 per share, and an increase next year of $0.32 per share.
Technical Analysis of Akebia Therapeutics
Should I short Akebia Therapeutics stock?
-
AKBA Moving Average Covergence Divergence (MACD) indicator is 0.33, suggesting Akebia Therapeutics is a Buy
-
Akebia Therapeutics Relative Strength Index (RSI) is 62.64, which suggest Akebia Therapeutics is overbought
-
The Bollinger Bands (25) for Akebia Therapeutics is (2.61 - 3.59), which suggest Akebia Therapeutics is a Buy
-
The Bollinger Bands (100) for Akebia Therapeutics is (1.79 - 2.89), which suggest Akebia Therapeutics is a Buy
* Akebia Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.